|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 205/04 | |
| C07D 413/12 | |||
| C07D 403/12 | |||
| C07D 401/12 | |||
| C07D 417/12 | |||
| A61K 31/397 | |||
| A61P 29/00 | |||
| A61P 37/00 |
| (11) | Patento numeris | 1781606 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05776965.5 |
| Europos patento paraiškos padavimo data | 2005-08-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/008654 |
| Data | 2005-08-09 |
| (87) | Numeris | WO 2006/015854 |
| Data | 2006-02-16 |
| (30) | Numeris | Data | Šalis |
| 0417801 | 2004-08-10 | GB |
| (72) |
LEGRAND, Darren Mark, GB
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
NOVARTIS-PHARMA GMBH, Brunner Strasse 59, 1230 Vienna, AT |
| (54) | AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS |
| AZETIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS |